USFDA nod to AstraZeneca, MSD's Lynparza plus Abiraterone and Prednisone or Prednisolone for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Ruchika Sharma2 Jun 2023 10:00 AM GMTRahway: AstraZeneca and Merck, known as MSD outside of the United States and Canada, has announced that LYNPARZA in combination with abiraterone...
AstraZeneca discontinues brazikumab inflammatory bowel disease development programme Ruchika Sharma2 Jun 2023 8:00 AM GMTCambridge: AstraZeneca has announced the discontinuation of the brazikumab inflammatory bowel disease (IBD) development programme, an anti-IL-23...
AstraZeneca Pharma India names Bhavana Agrawal as new CFO Ruchika Sharma1 Jun 2023 12:00 PM GMTBangalore: AstraZeneca Pharma India Ltd., a leading biopharmaceutical company, has announced the appointment of Bhavana Agrawal as Chief Finance...
AstraZeneca Ultomiris gets Japanese nod for prevention of relapses in patients with neuromyelitis optica spectrum disorder Ruchika Sharma28 May 2023 5:30 AM GMTNMOSD is a rare and debilitating autoimmune disease that affects the central nervous system, including the spine and optic nerves.
AstraZeneca to leave leading US drug lobby group Ruchika Sharma17 May 2023 8:00 AM GMTAstraZeneca's exit follows those of AbbVie, maker of blockbuster arthritis drug Humira, and Teva, a leading manufacturer of generic drugs.
AtraZeneca's Ultomiris approved in EU for adults with neuromyelitis optica spectrum disorder Ruchika Sharma12 May 2023 8:00 AM GMTNeuromyelitis optica spectrum disorder is a rare and debilitating autoimmune disease that affects the central nervous system including the spine and...
AstraZeneca Farxiga approved in US to reduce risk of cardiovascular death, hospitalisation for heart failure to broader range of patients Ruchika Sharma10 May 2023 7:00 AM GMTCambridge: AstraZeneca has announced that Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death,...
AstraZeneca Koselugo gets Chinese nod for paediatric patients with neurofibromatosis type 1, plexiform neurofibromas Ruchika Sharma9 May 2023 7:00 AM GMTIn addition to China, Koselugo is also approved in the US, EU, Japan and several other countries for the treatment of paediatric patients with NF1 and...
DCGI okays AstraZeneca's breast cancer drug Trastuzumab deruxtecan Ruchika Sharma4 May 2023 7:11 AM GMTThe HER2 is a tyrosine kinase receptor growth-promoting protein expressed on the surface of multiple tumours including breast, gastric, lung and...
AstraZeneca India to launch centres of excellence for severe asthma in Delhi, Ahmedabad, Kochi and Goa MD Bureau3 May 2023 8:00 AM GMTThe Centers of Excellence for severe asthma, as per the guidelines established by the Global Initiative for Asthma, would concentrate on specialty and...
AstraZeneca beat expectations for first-quarter profit, revenue Ruchika Sharma30 April 2023 6:45 AM GMTLondon: AstraZeneca on Thursday beat expectations for its first-quarter profit and revenue, helped by sales of its roster of drugs in emerging...
USFDA panel backs restricted use of AstraZeneca Prostrate cancer drug Ruchika Sharma29 April 2023 7:00 AM GMTLynparza belongs to a class of drugs called PARP inhibitors, which include Clovis Oncology's Rubraca and GSK Plc's Zejula.
